Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Inventory (2016 - 2025)

Historic Inventory for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $38.1 million.

  • Collegium Pharmaceutical's Inventory rose 5.26% to $38.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 5.26%. This contributed to the annual value of $35.6 million for FY2024, which is 998.39% up from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Inventory stood at $38.1 million, which was up 5.26% from $38.1 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Inventory registered a high of $80.1 million during Q1 2022, and its lowest value of $15.5 million during Q1 2021.
  • Its 5-year average for Inventory is $37.4 million, with a median of $34.1 million in 2023.
  • Its Inventory has fluctuated over the past 5 years, first soared by 41713.77% in 2022, then tumbled by 6653.42% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Inventory (Quarter) stood at $17.4 million in 2021, then skyrocketed by 167.34% to $46.5 million in 2022, then plummeted by 30.47% to $32.3 million in 2023, then grew by 9.98% to $35.6 million in 2024, then rose by 7.01% to $38.1 million in 2025.
  • Its last three reported values are $38.1 million in Q3 2025, $38.1 million for Q2 2025, and $37.2 million during Q1 2025.